DELRAY BEACH, Fla., March 11, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the Sterilization Equipment Market is projected to grow from about USD 19.39 billion in 2026 to USD 27.60 billion by 2031, at a CAGR of 7.3%.

Browse 614 market data Tables and 50 Figures spread through 550 Pages and in-depth TOC on "Sterilization Equipment Market- Global Forecast to 2031"

Sterilization Equipment Market Size & Forecast:

• Market Size Available for Years: 2025–2031
• 2026 Market Size: USD 19.39 billion
• 2031 Projected Market Size: USD 27.60 billion
• CAGR (2026–2031): 7.3%

Sterilization Equipment Market Trends & Insights:

• By product & service, the sterilization consumables & accessories segment is expected to register the highest CAGR of 10.6% during the forecast period.
• By technology, the heat/high-temperature sterilization segment accounted for the largest market share of 45.7% in 2025.
• By end user, the hospitals & clinics segment accounted for the largest market share of 42.1% in 2025.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=642

The market expansion is primarily driven by rising rates of hospital-acquired infections (HAIs) and by healthcare facilities improving their infection control systems. The demand is driven by several key factors, including the rising number of surgical procedures, the development of hospital infrastructure in emerging markets, and increasing regulatory scrutiny. Additionally, the increasing implementation of advanced low-temperature equipment and automated sterilization equipment is supporting market growth.

By product & service, the sterilization instruments segment accounted for the largest market share in 2025.

The market for sterilization equipment, by product & service, is segmented into sterilization instruments, sterilization services, and sterilization consumables & accessories. The growth of the sterilization instruments segment is mainly fueled by the rising incidence of hospital-acquired infections, an increasing number of surgical procedures, and strict regulatory requirements for infection control. Additionally, the global pharmaceutical and medical device industries are expanding, leading to greater demand for sterilization instruments.

Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=642

By end users, the medical device companies segment is projected to register the highest growth during the forecast period.

The end users in the sterilization equipment market include pharmaceutical companies, hospitals & clinics, medical device companies, and food & beverage companies. The medical device companies segment is experiencing growth due to several key factors. These include increased medical device production and strict regulations requiring sterilization validation during manufacturing. The rising complexity of medical devices, along with the growing need to maintain sterility and ensure quality during production, is driving a surge in demand for sterilization equipment among medical device companies.

North America dominated the sterilization equipment market in 2025.

The sterilization equipment market is divided into 5 major regions: Asia Pacific, Latin America, North America, Europe, and the Middle East & Africa. North America held the largest share of the sterilization equipment market in 2025. The sterilization equipment market in this region is growing due to its well-developed medical facilities, high surgical volume, and rising cases of hospital-acquired infections. The region experiences high demand for sterilization equipment due to its strong pharmaceutical and medical device manufacturing presence and strict regulations on sterilization and infection control.

Inquire Before Buying@ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=642

Top Companies in Sterilization Equipment Market:

The Top Companies in Sterilization Equipment Market include STERIS (US), Getinge AB (Sweden), Fortive (US), Solventum (US), Sotera Health (US), Cardinal Health (US), MMM Group (Germany), ANTONIO MATACHANA, S.A. (Spain), Miele Group (Germany), and Tuttnauer (Netherlands).

Browse Adjacent Markets: Medical Devices Market Research Reports & Consulting

Related Reports:

Sterilization Services Market - Global Forecast to 2030

Infection Control Market - Global Forecast to 2030

Surface Disinfectant Market - Global Forecast to 2030          

Cleanroom Technologies Market - Global Forecast to 2031

Medical Device Manufacturing Equipment (by Production) Market - Global Forecast to 2030

About MarketsandMarkets™ 

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

MarketsandMarkets™ SalesPlay is an AI-driven Revenue Intelligence Co-Pilot designed to help revenue teams prioritize the right accounts, identify critical changes early, and surface opportunities ahead of demand, so pipeline builds naturally and deals close with greater consistency.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:

Mr. Rohan Salgarkar

MarketsandMarkets™ INC.

1615 South Congress Ave.

Suite 103, Delray Beach, FL 33445

USA: +1-888-600-6441

Email: sales@marketsandmarkets.com

Visit Our Website: https://www.marketsandmarkets.com/

Logo: https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg 

View original content:https://www.prnewswire.co.uk/news-releases/sterilization-equipment-market-worth-27-60-billion-by-2031--marketsandmarkets-302710817.html

Lindt & Sprüngli liefert operative Rekordzahlen – und erlebt an der Börse dennoch einen heftigen Rückschlag. Die Partizipationsscheine des Premiumschokoladen-Herstellers brachen am Dienstag im frühen Handel zeitweise bis auf 11'000 Franken ein, ein Minus im Tief von deutlich über 7 Prozent. Auslöser ist nicht das vergangene Geschäftsjahr, in dem Lindt EBIT, Reingewinn und Marge im Rahmen oder leicht über den Konsensschätzungen abgeliefert hat, sondern die spürbar zurückgenommene Wachstumsprognose für das laufende Jahr.

Nach einem preisgetriebenen Umsatzplus und einer EBIT-Marge von rund 16,4 Prozent im Jahr 2025, die damit innerhalb der eigenen Zielspanne lag, stellt der Konzern für 2026 nur noch ein organisches Wachstum von 4 bis 6 Prozent in Aussicht. Zuvor lag der Korridor bei 6 bis 8 Prozent. Bereits für das laufende Jahr hatte Lindt seine „übliche“ Wachstumsbandbreite von 6 bis 8 Prozent im Januar noch bestätigt, nur um sie nun auf 4 bis 6 Prozent zu senken. Begründet wird dies mit geopolitischen Spannungen rund um den Iran-Krieg, höheren Energiepreisen, gedämpfter Konsumstimmung und möglichen Belastungen für den Tourismus – was speziell die Verkäufe an Flughäfen und in touristischen Hotspots treffen könnte.

Ein Teil der Analysten zweifelt jedoch daran, dass geopolitische Risiken die alleinige oder wesentliche Erklärung für die vorsichtigere Tonlage sind. So verweist Bernstein auf den vergleichsweise geringen Anteil des Nahen Ostens am Gesamtumsatz von Lindt von lediglich rund 1 bis 2 Prozent. Für Beobachter wie Vontobel-Analyst Jean-Philippe Bertschy signalisiert die neue Guidance daher vor allem Unsicherheit darüber, ob der Konzern nach einem Jahr, in dem das Wachstum praktisch komplett aus massiven Preiserhöhungen und nicht aus steigenden Volumen kam, die Absatzmengen 2026 tatsächlich wieder erhöhen kann.

Gleichzeitig fährt Lindt die Aktionärsvergütung deutlich hoch. Die Dividende soll für das abgelaufene Jahr stärker als erwartet steigen: Je Namenaktie werden 1'800 Franken in Aussicht gestellt – rund 200 Franken mehr als die Analystenschätzungen. Zudem plant das Unternehmen ein neues Aktienrückkaufprogramm von bis zu 1 Milliarde Franken und erhöht die Dividende beim Partizipationsschein auf 180 Franken. Nach einer rund 19-prozentigen Preiserhöhung im Jahr 2025, die trotz rückläufiger Verkaufsvolumina für ein Umsatzwachstum von 8,2 Prozent auf 5,92 Milliarden Franken sorgte, richtet Lindt damit seine Kapitalallokation stärker auf Ausschüttungen aus. An der Börse überlagern allerdings Zweifel an der künftigen Wachstumsdynamik derzeit den positiven Cashflow-Ausweis – der Bewertungsbonus einer vermeintlich verlässlichen Wachstumsgeschichte steht zur Disposition.